Apyx Medical (APYX) Return on Equity (2016 - 2025)
Historic Return on Equity for Apyx Medical (APYX) over the last 15 years, with Q3 2025 value amounting to 2.15%.
- Apyx Medical's Return on Equity rose 400.0% to 2.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.15%, marking a year-over-year increase of 400.0%. This contributed to the annual value of 1.14% for FY2024, which is 5600.0% down from last year.
- According to the latest figures from Q3 2025, Apyx Medical's Return on Equity is 2.15%, which was up 400.0% from 1.91% recorded in Q2 2025.
- In the past 5 years, Apyx Medical's Return on Equity registered a high of 0.24% during Q1 2021, and its lowest value of 2.18% during Q3 2024.
- Its 5-year average for Return on Equity is 0.9%, with a median of 0.56% in 2023.
- Its Return on Equity has fluctuated over the past 5 years, first tumbled by -17500bps in 2024, then surged by 400bps in 2025.
- Quarter analysis of 5 years shows Apyx Medical's Return on Equity stood at 0.28% in 2021, then plummeted by -108bps to 0.58% in 2022, then dropped by -7bps to 0.62% in 2023, then crashed by -196bps to 1.85% in 2024, then fell by -16bps to 2.15% in 2025.
- Its Return on Equity was 2.15% in Q3 2025, compared to 1.91% in Q2 2025 and 1.61% in Q1 2025.